These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 17100716)

  • 21. [Sudden cardiac death, ICD and resynchronization therapy].
    Schaumann A; Tack C; Kuck KH
    Herz; 2006 Dec; 31(9):857-63. PubMed ID: 17180648
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Trial-generated profiles for implantation of electrical devices in outpatients with heart failure: real-world prevalence and 1-year outcome.
    Boriani G; Rapezzi C; Diemberger I; Gonzini L; Gorini M; Lucci D; Sinagra G; Cooke RM; Di Pasquale G; Tavazzi L; Maggioni AP
    J Eval Clin Pract; 2010 Feb; 16(1):82-91. PubMed ID: 19874436
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Where patients with mild to moderate heart failure die: results from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT).
    Olshansky B; Wood F; Hellkamp AS; Poole JE; Anderson J; Johnson GW; Boineau R; Domanski MJ; Mark DB; Lee KL; Bardy GH;
    Am Heart J; 2007 Jun; 153(6):1089-94. PubMed ID: 17540216
    [TBL] [Abstract][Full Text] [Related]  

  • 24. How many patients fulfil the surface electrocardiogram criteria for subcutaneous implantable cardioverter-defibrillator implantation?
    Randles DA; Hawkins NM; Shaw M; Patwala AY; Pettit SJ; Wright DJ
    Europace; 2014 Jul; 16(7):1015-21. PubMed ID: 24351884
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Feasibility of implantable cardioverter defibrillator treatment in five patients with familial Friedreich's ataxia--a case series.
    Coskun KO; Popov AF; Schmitto JD; Coskun ST; Brandes I; Zenker D; Melnychenko I; Schoendube FA; Ruschewski W
    Artif Organs; 2010 Nov; 34(11):1061-5. PubMed ID: 21092049
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Electrical storm is an independent predictor of adverse long-term outcome in the era of implantable defibrillator therapy.
    Gatzoulis KA; Andrikopoulos GK; Apostolopoulos T; Sotiropoulos E; Zervopoulos G; Antoniou J; Brili S; Stefanadis CI
    Europace; 2005 Mar; 7(2):184-92. PubMed ID: 15763536
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sudden death prior to pediatric heart transplantation: would implantable defibrillators improve outcome?
    Rhee EK; Canter CE; Basile S; Webber SA; Naftel DC
    J Heart Lung Transplant; 2007 May; 26(5):447-52. PubMed ID: 17449412
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Implantable cardioverter-defibrillator implantation as a bridge to cardiac transplantation.
    Da Rosa MR; Sapp JL; Howlett JG; Falkenham A; Légaré JF
    J Heart Lung Transplant; 2007 Dec; 26(12):1336-9. PubMed ID: 18096488
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Influence of gender on ICD implantation for primary and secondary prevention of sudden cardiac death.
    Davis DR; Tang AS; Lemery R; Green MS; Gollob MH; Birnie DH
    Europace; 2006 Dec; 8(12):1054-6. PubMed ID: 17101630
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Competing risk analysis of cause-specific mortality in patients with an implantable cardioverter-defibrillator: The EVADEF cohort study.
    Marijon E; Trinquart L; Otmani A; Waintraub X; Kacet S; Clémenty J; Chatellier G; Le Heuzey JY;
    Am Heart J; 2009 Feb; 157(2):391-397.e1. PubMed ID: 19185651
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Obesity as a risk factor for sustained ventricular tachyarrhythmias in MADIT II patients.
    Pietrasik G; Goldenberg I; McNitt S; Moss AJ; Zareba W
    J Cardiovasc Electrophysiol; 2007 Feb; 18(2):181-4. PubMed ID: 17338766
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Implantable cardioverter-defibrillator in patients with chronic heart failure].
    Matsuda N
    Nihon Rinsho; 2006 May; 64(5):949-54. PubMed ID: 16689379
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Implantable cardioverter-defibrillator therapy for primary prevention of sudden death after alcohol septal ablation of hypertrophic cardiomyopathy.
    Cuoco FA; Spencer WH; Fernandes VL; Nielsen CD; Nagueh S; Sturdivant JL; Leman RB; Wharton JM; Gold MR
    J Am Coll Cardiol; 2008 Nov; 52(21):1718-23. PubMed ID: 19007692
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protection from outpatient sudden cardiac death following ICD removal using a wearable cardioverter defibrillator.
    Tanawuttiwat T; Garisto JD; Salow A; Glad JM; Szymkiewicz S; Saltzman HE; Kutalek SP; Carrillo RG
    Pacing Clin Electrophysiol; 2014 May; 37(5):562-8. PubMed ID: 24762055
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Improved survival associated with prophylactic implantable defibrillators in elderly patients with prior myocardial infarction and depressed ventricular function: a MADIT-II substudy.
    Huang DT; Sesselberg HW; McNitt S; Noyes K; Andrews ML; Hall WJ; Dick A; Daubert JP; Zareba W; Moss AJ;
    J Cardiovasc Electrophysiol; 2007 Aug; 18(8):833-8. PubMed ID: 17537209
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effectiveness of implantable cardioverter-defibrillators for the primary prevention of sudden cardiac death in women with advanced heart failure: a meta-analysis of randomized controlled trials.
    Ghanbari H; Dalloul G; Hasan R; Daccarett M; Saba S; David S; Machado C
    Arch Intern Med; 2009 Sep; 169(16):1500-6. PubMed ID: 19752408
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence and prognostic impact of comorbidities in heart failure patients with implantable cardioverter defibrillator.
    Bruch C; Bruch C; Sindermann J; Breithardt G; Gradaus R
    Europace; 2007 Aug; 9(8):681-6. PubMed ID: 17507354
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of the implantable defibrillator among elderly patients with a history of life-threatening ventricular arrhythmias.
    Healey JS; Hallstrom AP; Kuck KH; Nair G; Schron EP; Roberts RS; Morillo CA; Connolly SJ
    Eur Heart J; 2007 Jul; 28(14):1746-9. PubMed ID: 17283003
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic value of T-wave alternans in patients with heart failure due to nonischemic cardiomyopathy: results of the ALPHA Study.
    Salerno-Uriarte JA; De Ferrari GM; Klersy C; Pedretti RF; Tritto M; Sallusti L; Libero L; Pettinati G; Molon G; Curnis A; Occhetta E; Morandi F; Ferrero P; Accardi F;
    J Am Coll Cardiol; 2007 Nov; 50(19):1896-904. PubMed ID: 17980258
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Predictors of sudden cardiac death and appropriate shock in the Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) Trial.
    Saxon LA; Bristow MR; Boehmer J; Krueger S; Kass DA; De Marco T; Carson P; DiCarlo L; Feldman AM; Galle E; Ecklund F
    Circulation; 2006 Dec; 114(25):2766-72. PubMed ID: 17159063
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.